Nextrials, Inc. launched an Apple® iPad™ slate computer application for its clinical trial data management platform, Prism . The application supports mobile access to patient data in clinical trial and health care settings, helping physicians and researchers deliver superior care. It is also usable on an Apple iPhone™, and will be available as a free download later this year through the Apple® iTunes® Store.
Attendees at the 46th Annual Meeting of the Drug Information Association (DIA), being held June 13-17 at the Walter E. Washington Convention Center in Washington, DC, can get a first look at how Prism supports anytime/anywhere data access. In addition, DIA participants will see:
-Prism’s new design tools to foster faster study starts, the result of a recently announced strategic partnership with Formedix
-Nextrials’ participation in a live Healthcare Link demonstration showcasing shared data between clinical trial researchers and healthcare organizations, sponsored by the Clinical Data Interchange Standards Consortium
Nextrials’ Prism melds clinical trial management functionality with EDC in a single package. By receiving a constant flow of data, Prism enables sponsors and sites to fully utilize real-time integration of disparate information and data sources, such as a hospital’s EHR or patient records, to better provide a continuum of care for patients enrolled in clinical trials.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.
The State of the Opioid Epidemic
March 26th 2024In part 1 of this video interview, Greg Sturmer, co-founder and CEO of Elysium Therapeutics discusses the current state of opioid usage including how pain treatment is often mismanaged and how the industry can adopt greater safety standards in developing pain therapies.